Loading...

Insights

articles

The latest publications from Dr. Lanman and his collegues at Lanman Spine And Neurosurgery. VIEW ALL
June 07,2019

Sad inheritance: back and neck pain

Read More
May 24,2019

Artificial Disc Replacement: Faster recovery times and fewer complications.

Read More
May 10,2019

How artificial disc replacement keeps golfers in the game.

Read More

press

The latest publications about Dr. Lanman in print and digital media from around the world. VIEW ALL
SN-Logo-2016
June 12,2019

First-ever two-level M6 procedure performed in the USA

Spinal neurosurgeon Todd H Lanman has become the first US doctor to perform a two-level artificial disc replacement surgery using the newly US Food & Drug Administration (FDA) approved M6-C device from Orthofix. He performed the procedure with his Lanman Spinal Neurosurgery practice partner Jason Cuéllar at his side.   According to a press release, the M6-C

Read More
beckers-spine-1000x400-e1482957607154
June 11,2019

Drs. Todd Lanman and Jason Cuellar complete debut 2-level disc replacement with M6

Todd Lanman, MD, and Jason Cuellar, MD, PhD, of Beverly Hills, Calif.-based Lanman Spine Neurosurgery successfully performed the first spine procedures with Orthofix’s M6-C device.   Three insights:   1. Dr. Lanman previously performed the first artificial disc replacement with M6 in the U.S., while Dr. Cuellar assisted him in the completion of the first two-level artificial

Read More
May 09,2019

Chief Artificial Disc Replacement Innovator Dr. Todd Lanman Selected as Los Angeles’ Premier Provider of New FDA-Approved Anatomical M6 Cervical Disc Device

Los Angeles spinal neurosurgeon Dr. Todd H. Lanman continues to be at the forefront of spinal artificial disc replacement technology, once again leading the release of a new FDA-approved disc replacement device with the M6-C, a device with the first-ever viscoelastic core, which for the first time will mimic the natural structure and movement of

Read More

studies

Dr. Lanman's publications and research featured in the worlds leading medical journals. VIEW ALL
April 10,2017

Long-term clinical and radiographic outcomes of the Prestige LP artificial cervical disc replacement at 2 levels: results from a prospective randomized controlled clinical trial

OBJECTIVE The aim of this study was to assess long-term clinical safety and effectiveness in patients undergoing anterior cervical surgery using the Prestige LP artificial disc replacement (ADR) prosthesis to treat degenerative cervical spine disease at 2 adjacent levels compared with anterior cervical discectomy and fusion (ACDF).   Read More…

Read More
March 31,2017

Cervical disc arthroplasty with the Prestige LP disc versus anterior cervical discectomy and fusion, at 2 levels: results of a prospective, multicenter randomized controlled clinical trial at 24 months

OBJECTIVE The authors compared the efficacy and safety of arthroplasty using the Prestige LP cervical disc with those of anterior cervical discectomy and fusion (ACDF) for the treatment of degenerative disc disease (DDD) at 2 adjacent levels.   METHODS Patients from 30 investigational sites were randomized to 1 of 2 groups: investigational patients (209) underwent

Read More
July 12,2016

Access strategies for revision or explantation of the Charité lumbar artificial disc replacement

Todd H. Lanman, MD, FAANS, FACS (et al)   Many lumbar disc prostheses are constantly in development. The goal in each is to preserve mobility in patients with degenerative disc disease. In this study, Dr. Lanman and his colleagues examine the advantages and disadvantage of lumbar artificial disc replacement (ADR) compared with anterior interbody fusion

Read More

video channel

A collection of original video content from Dr. Lanman and his team at Lanman Spine and Neurosurgery. VIEW ALL

Meet Dr. Lanman and Hear His Story

WATCH OUR VIDEO

Follow Us | @drtoddlanman